David W Britt

Dr. David W Britt

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Lawrence DevoeLawrence Devoe
Lawrence Devoe
DBDavid W Britt
David W Britt
CMChristian R. Macedonia
Christian R. Macedonia
JWJaqueline M. Worth
Jaqueline M. Worth
GMGeorge M. Mussalli
George M. Mussalli
MEMark I Evans
Mark I Evans
Objective: Intrauterine resuscitation (IR) may be employed during labor to reduce emergency deliveries with concerns for fetal wellbeing emanating mostly from increased uterine contraction frequency and/or intensity. However, there is no standard definition of what constitutes IR, and how its impact is assessed. Here, we have created two measures of relative IR effectiveness, determined over a two-hour time frame after Pitocin was first initiated, and asked how fetal risk severity at the time of its initiation impacted IR effectiveness and the clinical decisions made. Methods: We analyzed 118 patients receiving Pitocin who underwent IR at least once during labor. Retrospectively, we assessed risk levels using our Fetal Reserve Index version 2 (FRI v2) scores that were calculated in 20 min timeframes. FRIv2 scores include various maternal, obstetric, and fetal risk factors, uterine contraction frequency, and FHR baseline rate, variability, accelerations, and decelerations. We define 3 IR scenarios to assess relative IR effectiveness. (1) No reduction in PIT infusion rates (PITSAME), (2) decreased PIT infusion rates (DPIT), or (3) PIT turned off (PIT OFF). Maternal repositioning and oxygen administration are nearly universal across all types and, therefore, are not considered in groupings. We then created two measures of IR effectiveness by classifying changes in FRI v2 scores over six 20 min windows coincident with and following IR use as (1) “Improvement” (improvement relative to the FRIv2 score at IR initiation) and (2) “Stabilization” (no further decrease in FRI score relative to the FRIv2 score in the sixth 20 min epoch after IR initiation). We evaluated the relative effectiveness of the three PIT options, and to test whether the level of fetal risk at the time of IR initiation affected its short-term effectiveness, FRI v2 risk scores were assigned to one of three groups (Green [1.00–0.625]; Yellow [0.50–0.25]; Red 0.25–0.0]). Higher scores indicate lower risk. Statistical analysis was performed with ANOVA and t- tests. Results: Overall, the first and/or the only initiation of IR resulted in improvement in 71% of cases and stabilization in 78% of cases. The remaining 22% were failures, meaning that the FRIv2 score in the 6th 20 min period was lower than the score at the time of initiation. There were modest, but not statistically significant, differences in effectiveness (improvement or stabilization) by type of IR. There was a trend toward lower IR effectiveness of PIT OFF during IR initiation when compared to PIT continuation or decreased groups. Conclusions: IR initiation or type did not vary significantly by retrospectively calculated levels of fetal risk, showing that wide variation in clinician practices, not necessarily correlated with what we believe actual risk was, determine how IR was used. The FRI provides contextualization of FHR elements by adding maternal, fetal, and obstetric risk factors, and increased uterine activity enables a more rigorous and reproducible approach to analysis of emerging fetal compromise and IR effectiveness. As practice has shifted from the over-aggressiveness of PIT use to now premature discontinuations with any tracing variation, we need better metrics. FRIv2 further improves its physiologic underpinnings. Thus, we propose a new approach to the overall assessment of IR practice.

23 March 2026 in Reproductive Medicine
Verified
Journal Article
Open access
PDF file
MEMark I Evans
Mark I Evans
LDLawrence D. Devoe
Lawrence D. Devoe
GRGregory Francis Ryan
Gregory Francis Ryan
DBDavid W Britt
David W Britt
CMChristian R. Macedonia
Christian R. Macedonia
Background/Objectives: Women’s health has historically lagged behind other medical specialties in transformative innovation, despite significant technological advances in adjacent fields. In this collection of papers, we examine the current state of innovation in women’s health and maternal–fetal medicine, identify barriers to transformation, and propose strategies for accelerating breakthrough developments. This paper presents an overview of multiple forces and their often-competing relationships that influence the environment in which advances in multiple areas of healthcare have had to navigate to enter mainstream practice. An understanding of these forces is essential to explain why some new technologies are readily deployed into clinical practice while others take many years to be adopted. Understanding the entire “echo-system” around any specific technology provides a much fuller understanding of how any individual advance can make its way into actual utilization. Methods: We synthesized current literature on innovation in women’s health, analyzing technological advances in artificial intelligence, precision medicine, non-invasive diagnostics, and surgical robotics. We examined patterns of innovation adoption and barriers to implementation across multiple domains. Results: Several key areas presented in this paper and the following show promise for transformative change: artificial intelligence (AI)-driven diagnostics achieving expert-level performance in prenatal screening, precision medicine approaches transforming genetic disease management, and non-invasive monitoring technologies revolutionizing maternal–fetal care. However, systemic barriers including regulatory complexity, liability concerns, and institutional inertia continue to limit widespread adoption of numerous breakthrough technologies. Conclusions: The convergence of multiple technological advances, particularly artificial intelligence and precision medicine, positions women’s health for unprecedented transformation. Success requires fostering innovation-ready environments, embracing systems-awareness approaches, and maintaining focus on human-centered care while leveraging technological capabilities with continual feedback and course corrections.

26 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
Lawrence DevoeLawrence Devoe
Lawrence Devoe
DBDavid W Britt
David W Britt
CMChristian R. Macedonia
Christian R. Macedonia
JWJaqueline M Worth
Jaqueline M Worth
GMGeorge M Mussallli
George M Mussallli
MEMark I Evans
Mark I Evans
Objective: Intrauterine resuscitation (IR) may be employed during labor to reduce emergency deliveries with concerns for fetal wellbeing emanating mostly from increased uterine contraction frequency and/or intensity. However, there is no standard definition of what constitutes IR and how its impact is assessed. Here, we have created two measures of relative IR effectiveness, determined over a two-hour time frame after Pitocin (PIT) was first initiated, and ask how fetal risk severity at the time of its initiation impacted IR effectiveness. Study Design: We analyzed 118 patients receiving PIT who underwent IR at least once during labor. Retrospectively, we assessed risk levels using our Fetal Reserve Index version 2 (FRI v2) scores that were calculated in 20-minute timeframes. FRIv2 scores include various maternal, obstetric, and fetal risk factors, uterine contraction frequency and FHR baseline rate, variability, accelerations, and decelerations. We define 3 IR scenarios to assess relative IR effectiveness. [1] no reduction of PIT infusion rates (PIT), [2] decreased PIT infusion rates (DPIT), or [3] PIT turned off (PIT OFF). Maternal repositioning and oxygen administration are nearly universal across all types, and therefore are not considered in groupings. We then created three measures of IR effectiveness by classifying changes in FRI v2 scores over six 20-minute windows coincident with and following IR use as: (1) “Improvement” (FRI score improvement), (2) “Stabilization,” (no further decrease in FRI score) and (3) failure. We evaluated the relative effectiveness of the three PIT options, and to test whether the level of fetal risk at the time of IR initiation affected its short-term effectiveness, FRI v2 risk scores were assigned to one of three groups (Green [1.00-0.625]; Yellow [0.50-0.25]; Red 0.25-0.0]). Higher scores indicate lower risk. Statistical analysis was performed with ANOVA and t- tests. Results: Overall, the first and/or the only initiation of IR resulted in improvement in 71% of cases and stabilization in 78% of cases. The remaining 22% were failures, meaning that the FRIv2 score in the 7th 20-minute period was lower than the score at the time of initiation. There were modest, but not statistically significant, differences in effectiveness (improvement or stabilization) by type of IR. There was a trend toward lower IR effectiveness of PIT OFF during IR initiation when compared to PIT continuation or decreased groups. Conclusions: IR initiation or type did not vary significantly by retrospectively calculated levels of fetal risk showing that wide variation in clinician practices determine how IR was used. The FRI provides contextualization of FHR elements by adding maternal, fetal, and obstetric risk factors and increased uterine activity enables a more rigorous and reproducible approach to analysis of emerging fetal compromise and IR effectiveness. FRIv2 further improves its physiologic underpinnings. Thus, we propose a new approach to the overall assessment of IR practice.

26 May 2026 in ACM Transactions on Computing for Healthcare
Verified
Journal Article
Open access
Abdullah MamunAbdullah Mamun
Abdullah Mamun
Lawrence DevoeLawrence Devoe
Lawrence Devoe
MEMark I Evans
Mark I Evans
DBDavid W Britt
David W Britt
Judith Klein-SeetharamanJudith Klein-Seetharaman
Judith Klein-Seetharaman
HGHassan Ghasemzadeh
Hassan Ghasemzadeh
Early detection of intrapartum risks enables timely interventions to prevent or mitigate adverse labor outcomes such as cerebral palsy. However, accurate automated systems to support clinical decision-making during delivery are currently lacking. To address this gap, we propose Artificial Intelligence for Modeling and Explaining Neonatal Health (AIMEN), a deep learning framework that predicts adverse labor outcomes from maternal, fetal, obstetrical, and intrapartum factors while providing interpretable reasoning behind its predictions. AIMEN reveals how specific modifications to input variables could alter predicted outcomes, enhancing clinical insight. To address class imbalance and limited sample size, AIMEN employs Conditional Tabular GAN (CTGAN) for data augmentation. This process includes synthetic data generation, and we investigate in detail properties such as relaxing feature bounds for a subset of training points to explore slightly out-of-range physiological values, and applying silhouette-score-based filtering to increase the separability of synthetic samples. AIMEN uses an ensemble of fully connected neural networks for classification and outperforms state-of-the-art models such as XGBoost, TabNet, DANet, and LightGBM, achieving an average F1 score of 0.784 in predicting high-risk deliveries. Moreover, AIMEN generates counterfactual explanations that identify actionable changes involving only two to three attributes on average. Resources: https://github.com/ab9mamun/AIMEN.